Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
14.43
+0.38 (2.70%)
At close: Mar 9, 2026, 4:00 PM EDT
14.50
+0.07 (0.49%)
After-hours: Mar 9, 2026, 4:46 PM EDT
Jade Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Net Income | -127.41 | -93.96 |
| Depreciation & Amortization | 0.03 | - |
| Loss (Gain) From Sale of Investments | -0.78 | - |
| Stock-Based Compensation | 20.01 | 2.51 |
| Other Operating Activities | 21.67 | 25.2 |
| Change in Accounts Payable | 0.36 | 2.58 |
| Change in Other Net Operating Assets | -8.56 | 18.44 |
| Operating Cash Flow | -94.69 | -45.23 |
| Capital Expenditures | -0.2 | - |
| Investment in Securities | -246.78 | - |
| Other Investing Activities | -0.03 | - |
| Investing Cash Flow | -247.01 | - |
| Total Debt Issued | - | 190 |
| Net Debt Issued (Repaid) | - | 190 |
| Issuance of Common Stock | 385.38 | - |
| Other Financing Activities | -24.62 | -6 |
| Financing Cash Flow | 360.77 | 184 |
| Foreign Exchange Rate Adjustments | -0.02 | - |
| Net Cash Flow | 19.05 | 138.77 |
| Free Cash Flow | -94.89 | -45.23 |
| Free Cash Flow Per Share | -3.03 | -14.33 |
| Levered Free Cash Flow | -61.22 | - |
| Unlevered Free Cash Flow | -58.97 | - |
| Change in Working Capital | -8.2 | 21.02 |
Source: S&P Capital IQ. Standard template.
Financial Sources.